Bharat Biotech ’s Chikungunya vaccine enters phase-1 clinical trials

In a statement, the company said “the placebo controlled study involving 60 healthy volunteers would test escalating doses of the vaccine in prime-boost regimen.”
Source: The Economic Times - Category: Consumer Health News Source Type: news